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Intestinal Retransplantation 
N. Jabbour, J. Reyes, S. Todo, J. Bueno, L. Mieles, S. Kocoshis, E. Yunis, and T.E. Starzl 
ADVANCEMENT in surgical technique, perioperative 
care, and the availability of effective immunosuppres-
sive agents has made intestinal transplantation a feasible 
procedure in patients with intestinal failure. Despite im-
provements in survival, however, the procedure still carries 
a higher patient and graft loss when compared to other 
organs. Re-transplantation (re-Tx) in this patient popula-
tion may be necessary in cases of primary graft failure. We 
present our experience with 6 patients who underwent 
re-Tx of intestinal allografts and discuss possible determi-
nants of survival. 
METHODS 
Six patients who underwent re-Tx of intestinal allografts after 
failure of the primary graft constitute our study population. Fol· 
lowing primary graft failure, evaluation for re-Tx focused on the 
cause of graft failure, the risk of disease recurrence, the presence of 
an ongoing viral or bacterial infection, and the immunological 
status of the patient. 
The re-Tx procedure consisted of either isolated intestine (SB), 
Liver/SB (LSB), or multivisceral (MV) abdominal organs. Immu-
nosuppression in all patients was based on tacrolimus (FK506) and 
steroids; azathioprine was added to certain patients with recurrent 
rejection or nephrotoxicity. I The post-operative care, nutritional 
and immunosuppressive management, and graft surveillance were 
as previously described for primary intestinal transplantation. I 
Follow-up time was defined until patient death or the time of 
completion of this study, and ranged between 19 to 251 days. 
RESULTS 
Intestinal allograft rejection was the main cause of intesti-
nal graft loss in five patients (PTLD was a contributing 
factor in two, and adenovirus hepatitis in another). Hepatic 
artery thrombosis (HAT) lead to the loss of the liver graft 
in one recipient. In LSB recipients, acute liver failure from 
HAT in 1, and adenovirus hepatitis in the second was the 
main reason for urgent re-Tx of the liver and LSB allografts 
at 11 and 60 days after the primary transplant respectively. 
Both patients died from sepsis at 19 and 47 days post re-Tx. 
A third LSB recipient suffered from chronic rejection of the 
intestinal allograft component. with a history of resolved 
PTLD. and normal liver function. Re-Tx with a MV graft 
was performed 462 days after the primary transplant and 
120 days after complete resolution of PTLD which was 
documented by endoscopy. intestinal biopsies. and CT 
scanning of chest and ahdomen. This patient died 57 days 
after re-Tx from fulminant PTLD. 
In isolated SB recipients. two recipients lost their grafts 
to rejection at 35 and 668 days. respectively. The SB graft 
was explantcd and an SB re-Tx performed 16 and 61 days 
thereafter. Both patients died in the ICU from sepsis. The 
third patient lost the initial SB graft from rejection and 
PTLD 774 days after the primary transplant. The primary 
intestinal allograft was explanted and an SB re-Tx was 
performed 340 days later. Prior to re-Tx the PTLD was 
completely cured as evidenced by endoscopies, cr scanning 
and EBV PCR of the peripheral blood. This patient is still 
alive 242 days after SB re-Tx, and is the only surviving 
patient in our series. 
DISCUSSION 
The timing and urgency of re-Tx were determinants of 
outcome in these patients. Urgent re-Tx of the liver allo-
graft alone in one patient (HAT), or USB graft in another 
(adenovirus hepatitis) resulted in their death from septic 
complications within 1 month of re-Tx. Technical difficulties 
along with suboptimal medical condition of the recipient 
(leU bound, on mechanical ventilation, and immunosup-
pressed) contributed to their demise. 
In the non-urgent re-Tx recipient, the cause of the 
primary graft failure, and the timing of the re-Tx were 
determinant factors. Rejection was the main cause of graft 
failure in 2 SB recipients, both of which had their graft 
removed 16 and 61 days before re-Tx, and both died 
following re-Tx from septic complications. Longer waiting 
time between graft removal and re-Tx would have allowed 
the recipient to clear any subclinical infection, and restore 
an immune system that was heavily suppressed shortly 
before graft enterectomy. 
The remaining two recipients (1 SB and 1 LSB) failed 
their primary graft to rejection and PTLD. One had re-Tx 3 
months after the PTLD was thought to be cured based on 
the available diagnostic tools. but died of fulminant PTLD 
within 2 months of re-Tx. The remaining patient underwent 
SB explantation 1 year prior to the re-Tx procedure. PTLD 
was completely cured prior to re-Tx as documented by the 
absence of any residual lesion. as well as a negative EBV 
PCR in the peripheral blood. The patient was also com-
pletely off immunosuppression during this time period 
between graft enterectomy and the re-Tx procedure. The 
immune response was normal at the time of re-Tx as 
evidenced by in vitro assays (MLR. response to third party 
antigens. and cytokine profile). Though he is the only 
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surviving patient, he suffered from severe rejection and 
EBV infection in the early post re-Tx period, which has 
resolved. We believe the longer time between graft removal 
and re-Tx played a major role in clearing the EBV and 
restoring a normal immune host response. 
CONCLUSION 
We conclude that intestinal re-Tx alone or with other 
abdominal organs is associated with high mortality and 
morbidity. Primary graft enterectomy and observation, al-
lowing all causes of first graft failure to be corrected and a 
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more stable medical condition can provide successful elec-
tive SB re-Tx. The risk of re-Tx in composite (LSB or MV) 
grafts is prohibitive, and should be considered under very 
selective criteria. 
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